The nucleotide sequence of aroH, the structural gene for the tryptophan-sensitive 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase [DAHPS(Trp)], is presented, and the deduced amino acid sequence of AroH is compared with that of the tyrosine-sensitive (AroF) and phenylalanine-sensitive (AroG) DAHPS isoenzymes, The high degree of sequence similarity among the three isoenzymes strongly indicates that they have a common evolutionary origin. In vitro chemical mutagenesis of the cloned aroH gene was used to identify residues and regions of the polypeptide essential for catalytic activity and for tryptophan feedback regulation. Missense mutations leading either to loss of catalytic activity or to feedback resistance were found interspersed throughout the polypeptide, suggesting overlapping catalytic and regulatory sites in DAHPS(Trp). We conclude that the specfficity of feedback regulation of the isoenzymes was probably acquired by the duplication and divergent evolution of an ancestral gene, rather than by domain recruitment.
In bacteria and plants, 3 -deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAHPS) (EC 4.1.2.15) catalyzes the first committed step in the pathway that leads to the biosynthesis of aromatic acids and vitamins. In Escherichia coli and other enteric bacteria there are three DAHPS isoenzymes (5) . Although catalyzing the same reaction (i.e., the condensation of erythrose-4-phosphate and phosphoenolpyruvate [PEP] to form 3-deoxy-D-arabino-heptulosonate 7-phosphate [DAHP]), each isoenzyme is feedback regulated by a different aromatic amino acid. The structural genes aroF, aroG, and aroH encode the tyrosine (Tyr)-, phenylalanine (Phe)-, and tryptophan (Trp)-inhibitable isoenzymes, respectively. The three genes are widely separated on the E. coli chromosome, aroF mapping at 57 min, aroG mapping at 17 min, and aroH mapping at 37 min (1) . Transcriptional control of aroF and aroG expression is mediated by the tyrR repressor (13) , and that of aroH is mediated by the trpR repressor (6, 23) . In wild-type cells grown in minimal medium, the AroG isoenzyme makes up about 80% of the total DAHPS activity, the AroF isoenzyme makes up 20%, and the AroH isoenzyme makes up about 1% (19) .
The aroF and aroG genes have been cloned and have been found to be similar in size and sequence (3, 4, 18) . When optimally aligned, 58% of the nucleotides and 53% of the amino acids of the derived polypeptide sequences are identical. The sequence identities are not evenly distributed throughout the two polypeptides, but are found predominantly in several extensive stretches in the interior of the molecules. These observations led Shultz et al. (18) to propose that the highly conserved regions of the polypeptides may be essential for their common catalytic activity, whereas the regions of low or no similarity may serve to enable the proper positioning of the other residues or to bestow regulatory specificity to each isoenzyme. It was also hypothesized that the genes may have evolved through rearrangement of functionally defined domains.
The aroH gene has also been cloned, and the sequence of * Corresponding author.
the 5' regulatory region and of the first 108 and last 354 nucleotides of the coding region has been reported (23) . In this report we present the complete nucleotide sequence of aroH and compare the amino acid sequences of the three DAHPS isoenzymes. We also describe the results of a mutational analysis undertaken to probe the regions of AroH that are essential for catalytic activity and for feedback regulation in order to test the existence of distinct functional domains in this isoenzyme.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli AB3248 (aroF363 aroG365 aroH367 proA2 argE3 ilv-7 his4 lac gal-2 tsx-358 thi) was isolated by Wallace and Pittard (20 (14) . However, this Trp sensitivity is alleviated in aroF aroG strains with multicopy aroH-, as used here, thereby necessitating the use of the analog, 5-MT, for the selection of aroH regulatory mutants.
Putative auxotrophic and MTR mutant clones were purified and retested. To eliminate mutations in the vector DNA, we excised the BamHI-EcoRI insert of each mutant plasmid and recloned it into untreated pBR322.
Restriction fragment exchange mapping. The plasmidborne mutations were localized within aroH by restriction fragment exchange mapping. Specific restriction fragments were removed from wild-type pAHH1 and replaced with the corresponding fragment from the mutant plasmids. The DNA fragments of the wild-type and mutant plasmid digests were separated in low-melting-temperature agarose and ligated in the presence of the agarose by using T4 DNA ligase (8) . The ligation mixture was used to transform AB3248 with selection on LB agar containing ampicillin. Transformants were tested for either the MTR or Aro-phenotype, as appropriate.
DNA sequencing. The wild-type aroH gene was first sequenced by the method of Maxam and Gilbert (10), using overlapping restriction fragments of plasmid pAROH924. The sequence was verified by the dideoxy-chain termination method (16), using restriction fragments of pAHH1 cloned into the replicative form of the M13mpl8 and M13mpl9 bacteriophage sequencing vectors. Aro-and MTR mutations were identified by dideoxy sequencing of the appropriate restriction fragment, as indicated by the results of the fragment exchange mapping.
Preparation of crude cell extracts. Cells were grown at 37°C in 100 ml of supplemented minimal medium (see above). The expression of aroH was derepressed by the addition of 100 ,ug of 2-p-indoleacrylic acid per ml (12) when the cultures reached an A550 of 0.5. Incubation was continued for 6 h, after which the cells were harvested and washed in 1 volume of 0.9% saline. The drained cell pellet was kept at -70°C overnight, thawed on ice, and then suspended in 5 ml of cold SPP (0.05 M potassium phosphate [pH 7.0] containing 100 ,ug of PEP per ml). All subsequent steps were carried out at 4°C. The cells were disrupted by sonication for 35 s at 70 W, a Branson sonifier (Branson Sonic Power Co., Danbury, Conn.). Cell debris was removed by centrifugation at 48,000 x g for 30 min. The supernatant was passed through a column of Sephadex G-25 (bed volume, 11 ml) equilibrated with SPP to remove residual 3-p-indoleacrylic acid and other small molecules.
Assay of DAHPS. DAHPS activity was assayed by a modification of the continuous spectrophotometric method described by Schoner and Herrman (17) . This method can be reliably used with crude extracts of strains carrying the aroH gene on a multicopy plasmid. The complete reaction mixture contained 10 mM BTP (pH 7.0), 100 ,uM PEP, and 300 ,uM erythrose-4-phosphate in a total volume of 1 of nearly identical sequence (i.e., residues 52 to 64, 86 to 110, 121 to 130, and 150 to 190). There is significantly less similarity in the carboxyl termini of the isoenzymes (46 identities in the last 157 residues) and little or none in the amino termini (6 identities in the first 41 residues).
In vitro construction of hybrid genes. The high degree of sequence similarity among the AroH, AroG, and AroF polypeptides strongly indicates that they have a common evolutionary origin. The clustered distribution of the sequence identities in the three homologs adds support to the speculation, made earlier by Shultz et al. (18) after comparing the AroF and AroG sequences, that the most highly conserved regions of the polypeptides may constitute homologous catalytic domains for substrate binding, whereas the less-conserved areas (for example, the carboxyl-terminal segment) may constitute nonhomologous regulatory domains for the binding of each specific feedback inhibitor. This idea was tested by the in vitro construction of in-frame hybrid forms of the aroH and aroF genes. This was made possible by the presence in the two genes of a conserved BanI restriction site located within the codon for Gly-187, which lies near the end of the highly conserved amino-terminal segment of the polypeptides ( Fig. 1 and 3) . It was reasoned that if the hybrid enzymes were functional, it might be possible to correlate the specificity of feedback inhibition in the DAHPS isoenzymes with either the aminoterminal or carboxyl-terminal half of the polypeptide.
The left and right arms of the aroH and aroF inserts of recombinant plasmids pAHH1 and pAFF1, separated by the BanI cleavage, were isolated and reciprocally exchanged by ligation in vitro. The hybrid inserts were then ligated into plasmid pBR322. The desired AroH-AroF and AroF-AroH hybrid plasmids were recovered by transformation into strain AB3248, an aroH aroF aroG triple mutant, with selection for Apr, and the structure of each hybrid plasmid was verified by restriction analysis. Subsequent testing showed that the transformants containing both the AroHAroF and AroF-AroH hybrid plasmids remained auxotrophic. The The mutations were localized to one of three segments of the aroH insert of pAHH1 by restriction fragment exchange mapping as follows. Wild-type pAHH1 DNA (Fig. 1 ) was doubly digested with either BamHI and PstI, PstI and KpnI, or KpnI and EcoRI, thereby excising specific segments of the aroH insert. The large vector fragments were isolated and ligated with the appropriate restriction fragments prepared from each mutant plasmid, reconstructing the aroH gene; the ligated DNA was transformed into strain AB3248 with selection for Apr. Transformants were then tested for the Aro-or MTR phenotype, as appropriate. By this method, mutations were mapped to the 890-base-pair BamHI-Pstl fragment, the 355-base-pair PstI-KpnI fragment, or the 702-base-pair KpnI-EcoRI fragment of the insert DNA of pAHH1. Both Aro-and MTR mutations were found in all three segments of the aroH insert (Table 1) .
To differentiate MTR mutants that are the desired AroH feedback-resistant types from those that have alterations of the aroH operator, we analyzed the repressibility of aroH expression in each MTR strain. Cultures were grown in supplemented minimal medium and supplemented minimal medium containing Trp, crude extracts were prepared, and DAHPS specific activity was assayed. Of the 10 mutants, 2 possessed constitutive levels of DAHPS activity; in both, the activity displayed wild-type sensitivity to feedback inhibition by Trp. The mutations of both strains mapped to the BamHI-PstI fragment, which contains the upstream regulatory sequences (Fig. 1) . It was therefore assumed that these are aroH operator mutants; they were not characterized further.
Appropriate restriction fragments containing the Aro-and MTR mutations were excised from the plasmids and cloned into bacteriophage vector M13mpl8 or M13mpl9 to identify the mutational changes by DNA sequencing. The nature and location of each change are presented in Table 1 and Fig. 3 . All but one of the mutations resulted from a change of a single nucleotide. The exception (aroH3) has a change of two adjacent nucleotides; however, this results in the change of only one amino acid. Of the 15 Aro-mutations, 13 are missense and 2 are nonsense types. Two mutants, E142K and R232C, were recovered more than once.
It is noteworthy that auxotrophic and feedback-resistant mutations are found interspersed rather than segregated and are scattered throughout the length of the AroH polypeptide (Fig. 3) . It is also striking that all of the Aro-missense changes are in residues that are invariant among the three isoenzymes. In contrast, the MTR mutations are found predominantly in residues that are nonconserved.
Feedback inhibition of the DAHPS of MTR mutants. The DAHPS activity of crude extracts of 2-,-indoleacrylic acidinduced cultures of AB3248 carrying pAHHI and the various MTR plasmids was assayed for sensitivity to feedback inhibition by Trp (Fig. 4) . The wild-type enzyme was inhibited to a maximum of about 50%, as has been previously reported (2, 14) . The DAHPS activity of five of the MTR mutants (those with changes P18L, V147M, G149D, G149C, and A177T) was completely resistant to Trp inhibition, whereas that of another (Q272R) was partially resistant. The other two mutants (G149S and A293T) showed anomalous behavior. The DAHPS activity of the former was about as Trp sensitive as the wild-type enzyme, whereas that of the latter appeared to have enhanced sensitivity to the inhibitor. The possibility that the MTR phenotype of these two strains is the result of a specific insensitivity of their DAHPS to inhibition by 5-MT has been excluded (data not shown). Thus, this anomaly appears to be a manifestation of differences in the feedback properties of the two enzymes in vivo and in vitro.
The wild-type and mutant enzymes were also assayed for feedback sensitivity to Tyr and Phe, the specific inhibitors of the AroF and AroG isoenzymes, respectively, and to chorismic acid, which regulates DAHPS in other bacterial species (21) . Neither the wild-type nor any of the mutant enzymes were found to exhibit significant sensitivity (i.e., greater than 20%o inhibition) to any of these metabolites, even at concentrations as high as 300 ,uM.
DISCUSSION
The high degree of sequence similarity among the AroH, AroG, and AroF polypeptides is convincing evidence that the three isoenzymes have a common evolutionary origin. It has been previously suggested that the three DAHPS homologs might have arisen during evolution by the combination of pre-existing parts of different origins (18) . For example, it can be speculated that the genetic fusion of a common ancestral catalytic domain with different amino acid (i.e., Trp, Phe or Tyr)-binding domains has led to the attainment of specific feedback regulation in each isoenzyme (21) . This possibility is consistent with the great variations in sequence homology in different regions of the polypeptides (Fig. 3) . However, the results of the mutational probing of the AroH isoenzyme reported here do not support this idea.
Rather than being localized to discrete regions of the polypeptide, missense mutations that eliminate catalytic activity are found throughout the aroH gene and are interspersed with those that alter or remove feedback regulation in the enzyme. This indicates that the functionally important regions of DAHPS(Trp) are not physically separate and probably include overlapping sequences. From these results it now appears certain that the three isoenzymes arose by the duplication and divergent evolution of a common ancestral gene, as has been recently proposed by Pittard (13) . Our finding that the AroH-AroF and AroF-AroH hybrid proteins lack catalytic activity is consistent with this, implying the coevolution of the amino-terminal and carboxylterminal segments of each DAHPS isoenzyme.
All of the catalytic aroH mutations analyzed thus far alter amino acid residues that are totally conserved in the three isoenzymes (Fig. 3) . Furthermore, many of these are located within one of the major blocks of sequence conservation in the amino-terminal half of the polypeptide. It is not yet clear which mutations are identifying residues essential for substrate binding and which might be causing structural instability or alterations in conformation. However, the occurrence of adjacent, inactivating mutations in residues Gly-162, Ala-163, and Arg-164 (Fig. 3) is particularly noteworthy. These residues, being located within one of the highly conserved sequence blocks (Fig. 3) , are attractive candidates as components of the active site of the enzyme.
In contrast to the inactivating missense mutations in AroH, seven of the eight mutations that alter feedback regulation of the enzyme change residues that are not rigidly conserved in the three isoenzymes. Three of the residues important for feedback regulation, namely Val-147, Gly-149, and Thr-177, flank the putative active-site residues, Gly-162, Ala-163, and Arg-164, mentioned above. Gly-149 appears to be of particular significance, since MTR mutants with three different changes have been recovered. One of these (G149C) is a G-to-T transversion, which presumably arose spontaneously. Feedback inhibition of DAHPS(Phe) by Phe and DAHPS(Tyr) by Tyr has been shown to be competitive with the substrate PEP (11, 16) . Assuming that Trp inhibition of DAHPS(Trp) is also competitive for PEP, it may be that residues 140 to 180 of AroH are structural components of overlapping binding sites for Trp and PEP.
The above speculations are based on the assumption that inherent in each AroH polypeptide is an active site for substrate binding and a feedback site for Trp binding. Since the active form of DAHPS(Trp) is a homodimer (J. M. Ray and R. Bauerle, unpublished results), the possibility exists that the holoenzyme possesses a composite active site(s) and/or feedback site(s), assembled from residues of both of the AroH subunits. However, there is at present no evidence supporting this type of structure in DAHPS(Trp) (2) or in the more extensively studied dimeric DAHPS(Tyr) and tetrameric DAHPS(Phe) isoenzymes (11, 17) .
Comparisons of the AroH sequence with those of other proteins have not been informative in the identification of putative active-site or feedback site sequences. Other than the strong homologies that exist among the three DAHPS isoenzymes, AroH does not share significant sequence homology with any other proteins of known structure, as indicated by global searches of the GenBank (edition 56) and National Biomedical Research Foundation (edition 17) sequence data bases with the FASTP program (stringency Ktup2) of Lipman and Pearson (9) . Furthermore, pairwise comparisons of AroH with other bacterial proteins that are known to bind one or more of the aromatic amino acids, including TrpE (anthranilate synthase component I), TrpR (tryptophan repressor), TrpS (tyrosyl-tRNA synthetase), TyrR (tyrosine repressor), TyrA (chorismate mutase-prephenate dehydrogenase), PheA (chorismate mutase-prephenate dehydratase), and TnaA (tryptophanase), also revealed no significant sequence homologies. A number of enzymes that bind phosphorylated compounds have been found to have the sequence Gly-X-Gly-X-X-Gly at the amino-terminal end of an alpha helix where the compound binds (15 (Fig. 4) , rather than the expected loss of sensitivity. This observation is particularly surprising for the G149S mutant, since two other changes in this residue (G149D and G149C) lead to full feedback resistance under the same conditions of assay. Fragment exchange mapping and DNA sequencing have unequivocally shown that the MTR phenotype of the two strains derives from the single nucleotide change indicated in Table 1 . Also, the anomalous behavior is not due to a specific insensitivity to 5-MT, the selective agent in the mutant screen. It is possible that it derives from changes in the conformational state of the mutant enzymes in vitro or perhaps is a reflection of more subtle changes in the kinetic properties of these enzymes relative to those of the other MTR strains. Purification and kinetic characterization of the wild-type and mutant enzymes are currently under way.
